People | June 26, 2026
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
Objective Structured Clinical Examination (OSCE) are widely used to evaluate medical students' practical competencies, communication, professionalism, and clinical decision-making
In his 17-year career within Roche, Marco has held key global, regional, and affiliate leadership roles
As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%
The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Subscribe To Our Newsletter & Stay Updated
